Intralytix, Inc. is a biotechnology company focused on the discovery, production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings.

Bacteriophages (bacteria-eater: from the Greek phago meaning "to eat" or "to develop at the expense of") are the most abundant microorganisms on earth. They are the natural enemies of bacteria. Lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting anything else, ensuring an unprecedented level of safety for an antimicrobial.

In The News

Intralytix: Illuminating the Path to Safer Food Processing

By harnessing the natural power of these bacteriophages, Intralytix offers robust food safety products designed to target some of the deadliest foodborne bacterial pathogens, including L. monocytogenes and E. coli.

Intralytix receives Fast Track NIH SBIR contract to develop a universal, scale-independent AI-based platform for manufacturing high titer bacteriophage preparations for clinical applications

Intralytix, Inc. announced today that it has received a Phase I award in the amount of $299,672 with an option for a Phase II award in the amount of $1,498,045. This award is made through the Small Business Innovation Research (SBIR) program under a Fast-Track Phase I / Phase II program providing for up to $1.8 million from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).

Intralytix Receives SBIR Grant to Develop Phage Preparation for Reducing Vibrio parahaemolyticus Contamination of Foods

Intralytix, Inc. announced today that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Food and Agriculture (NIFA), an agency of the U.S. Department of Agriculture (USDA), for the development of a phage biocontrol solution for Vibrio parahaemolyticus in various food products, including seafood.

How bacteriophages can help us shape the microbiome

An interview with Alexander "Sandro" Sulakvelidze, President and CEO of Intralytix, Inc.

See more...



Technology

Food Safety

Environmental Sanitation

Veterinary Applications

Human Therapeutics

Probiotics